CardioSignal is pleased to announce the appointment of Dr. Blaž Mrevlje as its new Medical Director. In this role, Dr. Mrevlje will lead medical development at CardioSignal, contributing his expertise in clinical research, regulatory documentation, and medical communication to further advance the company's innovative solutions for heart disease detection.

CardioSignal announces a collaboration with Heart Center Mølholm, one of Denmark’s most esteemed private hospitals and pioneers in cutting-edge cardiac ablation. This partnership marks a significant step forward in improving post-procedure care for patients undergoing ablation treatment at Mølholm.

High detection accuracy for atrial fibrillation detection was established among a diverse group of patients suspected of arrhythmias, heart failure and coronary artery disease. Detection reliability is key when designing remote care initiatives in larger populations.

Korhonen will lead the development of CardioSignal’s novel gyrocardiography technology to speed up its adoption across new emerging clinical applications, primarily in heart failure and aortic stenosis.

Harnessing the motion sensors of a smartphone solves critical issues in health care resourcing and timely access to specialized tests in heart failure.

How digital strategies can overcome barriers in screening heart diseases.